Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer

/PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today...

Related Keywords

Zurich ,Züsz ,Switzerland ,Bali Muralidhar ,Prnewswire Anjarium Biosciences ,Stephen Yoo ,Medimmune Astrazeneca ,Anjarium Biosciences ,Abbott Labs ,Chief Executive Officer ,Chief Medical Officer ,Third Harmonic Bio ,Managing Partner ,Omega Funds ,Pfizer Ventures ,Surveyor Capital ,